603520.SH
Zhejiang Starry Pharmaceutical Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 7.98
+2.70%Next report
Analyst consensus
- Next report date
- Apr 28, 2027
- EPS estimate
- —
- Revenue estimate
- —
Latest reported
- Last report date
- Oct 29, 2026
- EPS actual
- CNY 0.01
- EPS estimate
- —
- Revenue actual
- CNY 594.0M
- Revenue estimate
- CNY 586.4M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- 1
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 29, 2026 | — | CNY 0.01 | — | CNY 594.0M |
| Aug 31, 2026 | — | CNY 0.04 | — | CNY 703.0M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Apr 28, 2027